相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。KRAS mutations in pancreatic circulating tumor cells: a pilot study
Birte Kulemann et al.
TUMOR BIOLOGY (2016)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
J. S. Ankeny et al.
BRITISH JOURNAL OF CANCER (2016)
Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial
Michail Ignatiadis et al.
EUROPEAN JOURNAL OF CANCER (2016)
Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer
Wendy Onstenk et al.
ONCOTARGET (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques
Jussuf T. Kaifi et al.
CANCER BIOLOGY & THERAPY (2015)
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings
Christy E. Cauley et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer
Birte Kulemann et al.
PANCREAS (2015)
Survival in ampullary cancer: Potential role of different KRAS mutations
Nakul P. Valsangkar et al.
SURGERY (2015)
Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines
Britta Stolze et al.
SCIENTIFIC REPORTS (2015)
Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy
Pierre Laurent-Puig et al.
CLINICAL CANCER RESEARCH (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
Gunnar Steinert et al.
CANCER RESEARCH (2014)
Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
Andrew D. Rhim et al.
GASTROENTEROLOGY (2014)
Tumor Heterogeneity Revealed by KRAS, BRAF, and PIK3CA Pyrosequencing: KRAS and PIK3CA Intratumor Mutation Profile Differences and Their Therapeutic Implications
Vivian Kosmidou et al.
HUMAN MUTATION (2014)
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G. Lohr et al.
NATURE BIOTECHNOLOGY (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
F. C. Bidard et al.
ANNALS OF ONCOLOGY (2013)
Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor
Stephen J. Murphy et al.
GASTROENTEROLOGY (2013)
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
Bianca Mostert et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer
Emma Pailler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
Takeshi Ogura et al.
JOURNAL OF GASTROENTEROLOGY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann et al.
NATURE (2013)
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
L. Khoja et al.
BRITISH JOURNAL OF CANCER (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Multimarker Gene Analysis of Circulating Tumor Cells in Pancreatic Cancer Patients: A Feasibility Study
Andreia de Albuquerque et al.
ONCOLOGY (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Changes of HER2 Status in Circulating Tumor Cells Compared With the Primary Tumor During Treatment for Advanced Breast Cancer
Elisabetta Munzone et al.
CLINICAL BREAST CANCER (2010)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Personalized Medicine in Non-Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor-Targeted Therapy?
Patrick J. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
S. J. Cohen et al.
ANNALS OF ONCOLOGY (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance
Zacharoula Panteleakou et al.
MOLECULAR MEDICINE (2009)
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
Paloma Cejas et al.
PLOS ONE (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
SnapShot: Ras signaling
Megan Cully et al.
CELL (2008)
Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result
Toshio Kurihara et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations
I Albanese et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
